Accueil
Détail de l'éditeur
Documents disponibles chez cet éditeur (470)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
FRANÇAIS : Ce rapport de l'OEDT offre un tour d'horizon du phénomène de la toxicomanie en Europe : il fournit des renseignements sur les différents types de consommation, des données comparatives d'ordre épidémiologique ou encore des chiffres [...]
Rapport
FRANÇAIS : Le quatrième rapport annuel de l'EMCDDA présente les données et statistiques comparées les plus récentes concernant les drogues et toxicomanies dans les Etats membres de l'Union Européenne. Après une présentation des traitements, de[...]
Rapport
Cette première édition révèle que le problème de drogue dans ces pays diffère radicalement de la situation d'il y a cinq à sept ans. Traditionnellement considérés comme des pays de "transit", ils sont devenus aujourd'hui une cible pour ce qui co[...]
Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]
Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]![4F-iBF. Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF) in the framework of the Council Decision on new psychoactive substances](https://bdoc.ofdt.fr/img_cache/7e33efc39198eaf1e40d0959f4782b57.png)
Rapport
This publication presents the data and findings of the risk assessment on N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. I[...]![4F-MDMB-BICA. Risk assessment report on a new psychoactive substance: methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dime-thylbutanoate (4F-MDMB-BICA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)](https://bdoc.ofdt.fr/img_cache/6d6ee6c5b9f7c52bafcd5ae74bfddbd6.png)
Rapport
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on 4F-MDMB-BICA. The report is intended for policymakers and decision-makers in the institu[...]
Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 5-(2-aminopropyl)indole, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant [...]![5F-MDMB-PINACA. Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA) in the framework of the Council Decision on new psychoactive substances](https://bdoc.ofdt.fr/img_cache/6f20846f8360d6f66b53ed7e780ed9f7.png)
Rapport
This publication presents the data and findings of the risk assessment on methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 N[...]
Rapport
This publication presents the data and findings of the risk assessment on N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 No[...]
Rapport
This publication presents the data and findings of the risk assessment on N-(1 phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 22 February 2017. On the basis of th[...]
Rapport
This publication presents the data and findings of the risk assessment on N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7[...]
Livre
A. CARTER ; CAPPS B. ; W. HALL, Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2009This report reviews developments in the neuroscience of addiction, explores how they might affect the way we view and treat drug problems, and considers the issues that they raise for drug policy in Europe. In language that is easily accessible,[...]
Congrès
M. REISINGER ; Aids and drug addiction in the European Community : treatment and mistreatment (1-2 july 1993; Brussels) ; ed. | Lisbon : OEDT / EMCDDA | 1993FRANÇAIS : Cet ouvrage est constitué des actes d'un séminaire sur le sida et la toxicomanie dans les douze états membres de la Communauté européenne. Le constat de départ est le suivant : depuis 1991, les usagers de drogues par voie intraveineu[...]
Chapitre
The alternatives to prison that may be offered to drug-using offenders cover a range of sanctions that may delay, avoid, replace or complement prison sentences for those drug users who have committed an offence normally sanctioned with imprisonm[...]
